课题基金 / 基金详情

Innate Immune Response Induces Apoptosis and Regulates Apoptosis-related Molecules in Human Biliary Epithelial Cells

Innate Immune Response Induces Apoptosis and Regulates Apoptosis-related Molecules in Human Biliary Epithelial Cells
先天免疫反应诱导细胞凋亡并调节人胆管上皮细胞中的细胞凋亡相关分子
批准号:
18590326
负责人:
HARADA Kenichi
金额:
$2.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

HARADA Kenichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Biliary epithelial cells possess the essential components of the innate immune system consisting of Toll-like receptors (TLRs) which recognize pathogen-associated molecular patterns (PAMPs) such as lipopolysaccharide (LPS). LPS is known to cause cell injury including apoptosis. We established human intrahepatic biliary epithelial cells (HIBECs) and examined the PAMPs-induced apoptosis in HIBECs. The distinct induction of apoptosis was not found by the treatment with any bacterial PAMPs, but in the condition of an inhibition of NF-KB-dependent protein synthesis, HIBECs undergo apoptosis by PAMPs in the manner of caspase-dependence. In contrast, stimulation with polyinosinic-polycytidylic acid (poly(I:C), a synthetic analog of viral dsRNA) induced the activation of transcription factors (NF-KB and interferon regulatory factor 3) and the production of interferon-β1 (IFN-β1) as potent antiviral responses in HIBECs. Moreover, poly(I:C) up-regulated the expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and both poly(I:C) and TRAIL reduced the viability of cultured human HIBECs by enhancing apoptosis. In conclusion, bacterial and viral PAMPs could induce the apoptosis in human biliary epithelial cells as a result of the biliary innate immune response, supporting the notion that biliary innate immunity is directly associated with the pathogenesis of cholangiopathies in biliary diseases such as primary biliary cirrhosis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fas- and LPS-induced apoptosis in intrahepatic biliary epithelial cells
Fas 和 LPS 诱导的肝内胆管上皮细胞凋亡
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Kenichi, Harada, Yasuni, Nakanuma]
通讯作者: Nakanuma
DOI: --
发表时间: 2006
期刊: Journal of clinical pathology
影响因子: 3.4
作者: [K. Harada;K. Isse;Y. Nakanuma]
通讯作者: K. Harada;K. Isse;Y. Nakanuma
胆道系自然免疫機構と原発性胆汁性肝硬変の病態形成への関与
参与胆道先天免疫系统和原发性胆汁性肝硬化的发病机制
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Harada K, Isse K, Nakanuma Y., 原田憲一]
通讯作者: 原田憲一
DOI: 10.1111/j.1478-3231.2006.01325.x
发表时间: 2006-10-01
期刊: LIVER INTERNATIONAL
影响因子: 6.7
作者: [Harada, Kenichi, Isse, Kumiko, Nakanuma, Yasuni]
通讯作者: Nakanuma, Yasuni
11
    Pathogenesis of biliary atresia-Interaction between biliary innate immunity and acquired immunity-
    • 批准号:
      20590338
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2008
    • 负责人:
      HARADA Kenichi
    • 依托单位:
    Asymmetric synthetic studies on jiadifenin, neurotrophic compound
    • 批准号:
      19790027
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.37万
    • 财政年份:
      2007
    • 负责人:
      HARADA Kenichi
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: